July 24, 2025

Tooth Loss, Gum Disease Linked to Stomach Cancer

Using sibling comparisons and nationwide registries, researchers evaluate how inflammation and tooth count independently affect gastric cancer risk in adults across Sweden.

Conexiant

July 24, 2025

Immunotherapy Combination: A Potential New Standard in Triple-Negative Breast Cancer

In the phase III ASCENT-04/KEYNOTE-D19 trial, the combination of the TROP2-directed antibody-drug conjugate sacituzumab govitecan-hziy plus the PD-1 inhibitor pembrolizumab in previously untreated pat...

The ASCO Post

July 23, 2025

FDA Grants Breakthrough Status to Melanoma Test

The FDA has granted Breakthrough Device designation to Castle Biosciences’ DecisionDx-Melanoma test, a gene expression profile assay designed to improve risk stratification and personalized care in cutaneous melanoma.

Conexiant

July 23, 2025

Medical Oddities: The Physics Behind Frown Lines

The physics of aging skin, herbal cancer hacks, a nasal fix for sniffles and more this week!

Conexiant

July 22, 2025

Are Patients Leading the PFAS Response?

As public awareness rises, doctors are being called to bridge the knowledge gap, offer screening, and guide patients through complex and evolving risks.

KFF Health News

July 21, 2025

Melanoma Risk Differs by Mole Count and Genetic Profile

A large study found distinct genetic and phenotypic risk patterns for nevus-associated and de novo invasive melanomas.

Conexiant

July 18, 2025

Blood Test Predicts Organ Aging and Mortality

Researchers used blood proteins to estimate the biological age of 11 organs in over 44,000 people, revealing that older brain and immune systems were linked to higher disease and death risks, while younger ones predicted longer life.

Conexiant

July 18, 2025

Decade of Data Validates Life’s Simple 7

A decade-long review supports that higher Life’s Simple 7 cardiovascular health scores significantly reduce risks of chronic disease, mortality, and health care use.

Conexiant

July 17, 2025

FDA Approves Shingrix Prefilled Syringe Option

The FDA has approved a new prefilled syringe presentation of Shingrix to simplify herpes zoster vaccination for eligible adult patients.

Conexiant